These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2402752)

  • 1. Physico-chemical properties of recombinant desulphatohirudin.
    Electricwala A; Irons L; Wait R; Carr RJ; Ling RJ; Grossenbacher H; Atkinson T
    Thromb Haemost; 1990 Jun; 63(3):499-504. PubMed ID: 2402752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of dextran-bound recombinant hirudin and its pharmacokinetic behaviour.
    Markwardt F; Richter M; Walsmann P; Riesener G; Paintz M
    Biomed Biochim Acta; 1990; 49(10):1103-8. PubMed ID: 1706917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental studies on a recombinant hirudin, CGP 39393.
    Gray E; Watton J; Cesmeli S; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1991 Apr; 65(4):355-9. PubMed ID: 2057916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the secondary structure of hirudin and the mechanism of its interaction with thrombin.
    Konno S; Fenton JW; Villanueva GB
    Arch Biochem Biophys; 1988 Nov; 267(1):158-66. PubMed ID: 3196024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure study of recombinant RGD-hirudin by vibrational and circular dichroism spectroscopy.
    Liu X; Mo W; Dai L; Yan X; Song H
    Protein Pept Lett; 2006; 13(1):47-51. PubMed ID: 16454669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weak allergenicity of recombinant hirudin CGP 39393 (REVASC) in immunocompetent volunteers. The European Hirudin in Thrombosis Group (HIT Group).
    Close P; Bichler J; Kerry R; Ekman S; Bueller HR; Kienast J; Marbet GA; Schramm W; Verstraete M
    Coron Artery Dis; 1994 Nov; 5(11):943-9. PubMed ID: 7719527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State of aggregation of recombinant hirudin in solution under physiological conditions.
    Thannhauser TW; Scheraga HA
    J Protein Chem; 1996 Nov; 15(8):751-3. PubMed ID: 9008299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic effects of recombinant hirudin in experimental angioplasty and intravascular thrombolysis.
    Kaiser B; Simon A; Markwardt F
    Thromb Haemost; 1990 Feb; 63(1):44-7. PubMed ID: 2140204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The characterisation of thrombus development in an improved model of arterio-venous shunt thrombosis in the rat and the effects of recombinant desulphatohirudin (CGP 39393), heparin, and iloprost.
    Peters RF; Lees CM; Mitchell KA; Tweed MF; Talbot MD; Wallis RB
    Thromb Haemost; 1991 Mar; 65(3):268-74. PubMed ID: 1710836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detailed physicochemical characterization of the 2S storage protein from rape (Brassica napus L.).
    Schmidt I; Renard D; Rondeau D; Richomme P; Popineau Y; Axelos MA
    J Agric Food Chem; 2004 Sep; 52(19):5995-6001. PubMed ID: 15366854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct thrombin inhibition with Rec-hirudin CGP 39393 as prophylaxis of thromboembolic complications after total hip replacement.
    Eriksson BI; Kälebo P; Ekman S; Lindbratt S; Kerry R; Close P
    Thromb Haemost; 1994 Aug; 72(2):227-31. PubMed ID: 7831657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressor p16INK4A: structural characterization of wild-type and mutant proteins by NMR and circular dichroism.
    Tevelev A; Byeon IJ; Selby T; Ericson K; Kim HJ; Kraynov V; Tsai MD
    Biochemistry; 1996 Jul; 35(29):9475-87. PubMed ID: 8755727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NMR solution structure of recombinant RGD-hirudin.
    Song X; Mo W; Liu X; Zhu L; Yan X; Song H; Dai L
    Biochem Biophys Res Commun; 2007 Aug; 360(1):103-8. PubMed ID: 17585879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1H NMR assignment and secondary structure of recombinant RGD-hirudin.
    Liu X; Yan X; Mo W; Song H; Dai L
    Magn Reson Chem; 2005 Nov; 43(11):956-61. PubMed ID: 16103990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of recombinant hirudin.
    Nowak G
    Semin Thromb Hemost; 2002 Oct; 28(5):415-24. PubMed ID: 12420236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anticoagulant mechanism of action of recombinant hirudin (CGP 39393) in plasma.
    Lindhout T; Blezer R; Hemker HC
    Thromb Haemost; 1990 Nov; 64(3):464-8. PubMed ID: 2096492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and purification of recombinant hirudin].
    Guo J; Wang H; Gu J
    Zhonghua Xue Ye Xue Za Zhi; 1998 Mar; 19(3):146-8. PubMed ID: 11243147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant desulphatohirudin (CGP 39393) anticoagulant and antithrombotic properties in vivo.
    Talbot MD; Ambler J; Butler KD; Findlay VS; Mitchell KA; Peters RF; Tweed MF; Wallis RB
    Thromb Haemost; 1989 Feb; 61(1):77-80. PubMed ID: 2749592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further physicochemical characterization of the novel human brain protein h3.
    Bollengier F; Beeckmans S; Mahler A; Kanarek L
    J Neurochem; 1989 Apr; 52(4):1123-6. PubMed ID: 2926393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression, purification and initial characterization of the recombinant storage protein precursor of Theobroma cacao.
    O'Connor J; Revell DF; Masters KE; Connerton IF; Sumner IG
    Protein Expr Purif; 1996 Jun; 7(4):377-83. PubMed ID: 8776755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.